News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Roche plans to launch its high-volume Elecsys SARS-CoV-2 Antigen test at the end of 2020 in markets accepting the CE mark; while the company will file for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA).
IONTAS has announced a deal with Bristol Myers Squibb (BMS) in relation to its platform for antibody identification.
Supply chain security will be vital to ensure effective and safe distribution of vaccines, says a traceability expert.
Johnson & Johnson has paused dosing in all its COVID-19 vaccine candidate clinical trials – including its Phase 3 trial – due to an unexplained illness in a study participant.